JP2021520380A5 - - Google Patents
Info
- Publication number
- JP2021520380A5 JP2021520380A5 JP2020554275A JP2020554275A JP2021520380A5 JP 2021520380 A5 JP2021520380 A5 JP 2021520380A5 JP 2020554275 A JP2020554275 A JP 2020554275A JP 2020554275 A JP2020554275 A JP 2020554275A JP 2021520380 A5 JP2021520380 A5 JP 2021520380A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- composition according
- hct
- years
- approximately
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862652722P | 2018-04-04 | 2018-04-04 | |
| US62/652,722 | 2018-04-04 | ||
| PCT/US2019/025716 WO2019195506A1 (en) | 2018-04-04 | 2019-04-04 | Methods of treating autism spectrum disorders using human umbilical cord tissue-derived mesenchymal stromal cells |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2021520380A JP2021520380A (ja) | 2021-08-19 |
| JP2021520380A5 true JP2021520380A5 (https=) | 2022-04-11 |
Family
ID=68101425
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020554275A Pending JP2021520380A (ja) | 2018-04-04 | 2019-04-04 | ヒト臍帯組織由来の間葉系間質細胞を使用して自閉症スペクトラム障害を処置する方法 |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US12491210B2 (https=) |
| EP (1) | EP3773486B1 (https=) |
| JP (1) | JP2021520380A (https=) |
| KR (1) | KR20210031853A (https=) |
| CN (1) | CN112351785A (https=) |
| AU (1) | AU2019247210A1 (https=) |
| BR (1) | BR112020020295A2 (https=) |
| CA (1) | CA3096033A1 (https=) |
| ES (1) | ES2968823T3 (https=) |
| IL (1) | IL277733B2 (https=) |
| SG (1) | SG11202009805PA (https=) |
| WO (1) | WO2019195506A1 (https=) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN113057969A (zh) * | 2021-03-09 | 2021-07-02 | 吴志新 | 一种间充质干细胞对儿童自闭症临床应用实验方法 |
| WO2025100424A1 (ja) * | 2023-11-10 | 2025-05-15 | 国立大学法人 東京大学 | 急性脳症治療剤及び急性脳症の治療方法 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2009046377A2 (en) * | 2007-10-04 | 2009-04-09 | Medistem Laboratories, Inc. | Compositions and methods of stem cell therapy for autism |
| US9347956B2 (en) | 2010-12-16 | 2016-05-24 | Autism Biotech Limited | Biomarker and uses thereof in diagnosis, treatment of autism |
| AU2017235446A1 (en) | 2016-03-16 | 2018-11-08 | Cell Medicine, Inc. | Mesenchymal stem cells with enhanced efficacy |
| US20170296588A1 (en) * | 2016-04-19 | 2017-10-19 | AngioStem, Inc. | Mesenchymal stem cells derived from placental sources |
| WO2017204231A1 (ja) * | 2016-05-24 | 2017-11-30 | 国立大学法人 東京大学 | 臍帯由来細胞を含む脳障害の治療剤 |
| US10987381B2 (en) | 2017-01-27 | 2021-04-27 | Neil Riordan | Mesenchymal stem cells with enhanced efficacy in treatment of autoimmunity particularly rheumatoid arthritis |
-
2019
- 2019-04-04 EP EP19781349.6A patent/EP3773486B1/en active Active
- 2019-04-04 IL IL277733A patent/IL277733B2/en unknown
- 2019-04-04 ES ES19781349T patent/ES2968823T3/es active Active
- 2019-04-04 WO PCT/US2019/025716 patent/WO2019195506A1/en not_active Ceased
- 2019-04-04 BR BR112020020295-9A patent/BR112020020295A2/pt not_active Application Discontinuation
- 2019-04-04 SG SG11202009805PA patent/SG11202009805PA/en unknown
- 2019-04-04 US US17/044,843 patent/US12491210B2/en active Active
- 2019-04-04 KR KR1020207031742A patent/KR20210031853A/ko not_active Ceased
- 2019-04-04 JP JP2020554275A patent/JP2021520380A/ja active Pending
- 2019-04-04 CN CN201980033345.8A patent/CN112351785A/zh active Pending
- 2019-04-04 CA CA3096033A patent/CA3096033A1/en active Pending
- 2019-04-04 AU AU2019247210A patent/AU2019247210A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US12205720B2 (en) | Digital qualimetric biomarkers for cognition and movement diseases or disorders | |
| Cirillo et al. | Post-stroke remodeling processes in animal models and humans | |
| Kouijzer et al. | Neurofeedback treatment in autism. Preliminary findings in behavioral, cognitive, and neurophysiological functioning | |
| Radmard et al. | Evaluation of cerebellar ataxic patients | |
| Kozlowski et al. | The control of movement following traumatic brain injury | |
| Mukherjee et al. | Intensive rehabilitation combined with HBO2 therapy in children with cerebral palsy: a controlled longitudinal study | |
| Modoni et al. | Long-term safety and usefulness of mexiletine in a large cohort of patients affected by non-dystrophic myotonias | |
| Preisler et al. | Effect of aerobic training in patients with spinal and bulbar muscular atrophy (Kennedy disease) | |
| JP2021520380A5 (https=) | ||
| Man et al. | Link between the skin and autism spectrum disorder | |
| Tu et al. | The neurobiological mechanisms underlying the effects of exercise interventions in autistic individuals | |
| Rossi-Izquierdo et al. | What could posturography tell us about balance in essential tremor? | |
| JP2020510049A5 (https=) | ||
| Moore et al. | Intensive teenage activity is associated with greater muscle hyperintensity on T1W magnetic resonance imaging in adults with dysferlinopathy | |
| Miznerova et al. | Virtual reality-based neuroproprioceptive physiotherapy in multiple sclerosis: a protocol for a double-arm randomised assessor-blinded controlled trial on upper extremity function, postural function and quality of life, with molecular and functional MRI assessment | |
| Dziadkowiak et al. | Establishing Diagnostic and Differential Diagnostic Criteria for Amyotrophic Lateral Sclerosis | |
| Zoccolella et al. | Neurophysiological indices for split phenomena: correlation with age and sex and potential implications in amyotrophic lateral sclerosis | |
| Peyre et al. | Computerized oculomotor training in dyslexia: A randomized, crossover clinical trial in pediatric population | |
| Koszewicz et al. | Motor fiber function in spinal muscular atrophy—analysis of conduction velocity distribution | |
| Capece et al. | Case Report: Laryngospasm as Initial Manifestation of Amyotrophic Lateral Sclerosis in a Long-Survival Patient With Heterozygous p. D90A–SOD1 Mutation | |
| Sharma et al. | Amelioration of autism by autologous bone marrow mononuclear cells and neurorehabilitation: a case report | |
| Alaydin et al. | The Role of the Cutaneous Silent Period in the Electrophysiological Diagnosis of Guillain–Barré Syndrome | |
| Czachowski | Functional disorders–new proposals for definition, classifications, etiology and therapies | |
| Van Oorsouw et al. | Side effects of contingent shock treatment | |
| US20180289655A1 (en) | Methods and Compositions for the Intravenous Administration of Fumarates for the Treatment of Neurological Diseases |